Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)Elaine Dennison, Cyrus Cooper, Stephen H. Gehlbach et al.|Bone|2012Cited by 148
The effect of 2 and 3 years of Raloxifene on vertebral and non-vertebral fractures in postmenopausal women with osteoporosisKristine E. Ensrud, B. Mitlak, D Black et al.|ORBi (University of Liège)|1998Cited by 21